HF 3876 Summary

• Changes the deadline for manufacturers to begin supplying medical cannabis from July 1, 2015 to within eight months of initial registration.

• Requires the commissioner to implement a state-centralized medical cannabis electronic database to track inventories from seed through cultivation, processing, testing, and distribution or disposal with instantaneous updates.

• Allows manufacturers to acquire and process hemp and hemp products into allowable forms of medical cannabis, subject to the same quality control and security requirements as medical cannabis.

• Permits pharmacist consultations for patient dosage determinations to be conducted remotely via secure videoconference, telephone, or other remote means while maintaining telehealth privacy requirements.

• Allows patients to purchase medical cannabis paraphernalia from non-registered manufacturers, while medical cannabis itself must be obtained from registered manufacturers.